Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, ...

Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, ...

Lars Fruergaard Jørgensen, Novo Nordisk CEO, joins 'Money Movers' to discuss Jorgensen's comments on demand in 2025, if demand is waning for GLP-1 drugs, and much more.

Novo Nordisk chief executive Lars Fruergaard Jørgensen was taken to task by US lawmakers over the price of the company's semaglutide drugs for diabetes and obesity at a congressional hearing ...

The chief executive of the drugmaker Novo Nordisk, Lars Fruergaard Jørgensen, is scheduled to face tough questions Tuesday on Capitol Hill about the high costs of the company’s widely popular w ...

Lars Fruergaard Jørgensen says "this ensures that our time and resources are focused on unlocking cures for chronic diseases, not on daily stock fluctuations". He then adds: "We know these ...

Novo Nordisk har tjent 72,8 milliarder kroner i årets første ni måneder. Det er 18 procent mere end i samme periode i 2023.

Bernie Sanders excoriated the CEO of Novo Nordisk (the manufacturer of Ozempic and Wegovy), Lars Fruergaard Jørgensen, because people in the U.S. pay an average of $969 per month for Ozempic ...

Novo Nordisk har tjent 72,8 milliarder kroner i årets første ni måneder. Det er 18 procent mere end i samme periode i 2023.